Anticardiolipin antibodies in patients on regular hemodialysis: an epiphenomenon?

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Nephron

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000187422PMID 8367001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease.

  1991cited by this paper
• The ‘antiphospholipid syndrome’ and the ‘lupus anticoagulant’

  1990cited by this paper
• Raised concentrations of antibodies to cardiolipin in patients receiving dialysis.

  1990cited by this paper

• The Role of Cardiolipin and Mitochondrial Damage in Kidney Transplant

  2019cites this paper
• Renal involvement in antiphospholipid syndrome

  2014cites this paper
• Thrombophilias and arteriovenous fistula dysfunction in maintenance hemodialysis

  2009cites this paper
• Kidney disease in antiphospholipid syndrome.

  2006cites this paper
• Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients.

  2006cites this paper
• IgM-Anticardiolipin Antibody and Vascular Access Thrombosis in Chronic Hemodialysis Patients

  2005cites this paper
• Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis

  2005cites this paper
• Hypercoagulability in Renal Transplant Recipients

  2004cites this paper
• Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients

  2004cites this paper
• Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention.

  2004cites this paper
• Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation.

  2003cites this paper
• Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis.

  2003cites this paper
• "Black swan in the kidney": renal involvement in the antiphospholipid antibody syndrome.

  2002cites this paper
• IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.

  2001cites this paper
• Association of anticardiolipin antibodies with vascular injury: possible mechanisms

  2000cites this paper
• Coagulation and haemodialysis access thrombosis.

  2000cites this paper
• Association of Anticardiolipin Antibodies with Vascular Access Occlusion in Hemodialysis Patients: Cause or Effect?

  2000cites this paper
• Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.

  1999cites this paper
• Renal allograft thrombosis: can thrombophilia explain the inexplicable?

  1999cites this paper
• Anticardiolipin antibodies in hemodialysis patients.

  1999cites this paper
• Antiphospholipid antibodies are a risk factor for early renal allograft failure.

  1999cites this paper
• Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: Relationship with vascular access thrombosis and thromboembolic events

  1999cites this paper
• Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis.

  1995cites this paper
• Increased prevalence of anticardiolipin antibodies in renal transplant recipients.

  1995cites this paper
• Autoantibodies and Other Autoimmune Serologic Abnormalities in Dialysis Patients

  1995cites this paper
• Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis.

  1995cites this paper
• Renal manifestations of the antiphospholipid syndrome.

  1994cites this paper